nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Citrulline—PADI1—decidua—cervical cancer	0.0611	0.0656	CbGeAlD
L-Citrulline—PADI1—uterus—cervical cancer	0.0534	0.0574	CbGeAlD
L-Citrulline—PADI3—renal system—cervical cancer	0.05	0.0538	CbGeAlD
L-Citrulline—PADI1—vagina—cervical cancer	0.0434	0.0467	CbGeAlD
L-Citrulline—PADI3—vagina—cervical cancer	0.0362	0.039	CbGeAlD
L-Citrulline—DDAH2—uterine cervix—cervical cancer	0.0313	0.0336	CbGeAlD
L-Citrulline—DDAH1—epithelium—cervical cancer	0.0304	0.0327	CbGeAlD
L-Citrulline—DDAH1—uterine cervix—cervical cancer	0.0302	0.0324	CbGeAlD
L-Citrulline—DDAH2—decidua—cervical cancer	0.0298	0.0321	CbGeAlD
L-Citrulline—DDAH1—decidua—cervical cancer	0.0288	0.0309	CbGeAlD
L-Citrulline—DDAH2—endometrium—cervical cancer	0.0283	0.0304	CbGeAlD
L-Citrulline—DDAH1—renal system—cervical cancer	0.0282	0.0304	CbGeAlD
L-Citrulline—DDAH2—mammalian vulva—cervical cancer	0.0274	0.0294	CbGeAlD
L-Citrulline—DDAH2—uterus—cervical cancer	0.0261	0.028	CbGeAlD
L-Citrulline—DDAH1—uterus—cervical cancer	0.0252	0.027	CbGeAlD
L-Citrulline—DDAH1—female reproductive system—cervical cancer	0.0226	0.0243	CbGeAlD
L-Citrulline—DDAH2—female gonad—cervical cancer	0.0213	0.0229	CbGeAlD
L-Citrulline—DDAH2—vagina—cervical cancer	0.0212	0.0228	CbGeAlD
L-Citrulline—DDAH1—female gonad—cervical cancer	0.0206	0.0221	CbGeAlD
L-Citrulline—NOS1—epithelium—cervical cancer	0.0203	0.0219	CbGeAlD
L-Citrulline—OTC—lymph node—cervical cancer	0.0192	0.0207	CbGeAlD
L-Citrulline—NOS1—renal system—cervical cancer	0.0189	0.0203	CbGeAlD
L-Citrulline—PADI2—lymph node—cervical cancer	0.0164	0.0176	CbGeAlD
L-Citrulline—ASS1—epithelium—cervical cancer	0.0155	0.0167	CbGeAlD
L-Citrulline—NOS3—epithelium—cervical cancer	0.0155	0.0166	CbGeAlD
L-Citrulline—ASS1—uterine cervix—cervical cancer	0.0154	0.0165	CbGeAlD
L-Citrulline—NOS1—female reproductive system—cervical cancer	0.0151	0.0162	CbGeAlD
L-Citrulline—ASS1—decidua—cervical cancer	0.0147	0.0158	CbGeAlD
L-Citrulline—ASS1—renal system—cervical cancer	0.0144	0.0155	CbGeAlD
L-Citrulline—NOS3—renal system—cervical cancer	0.0143	0.0154	CbGeAlD
L-Citrulline—ASS1—endometrium—cervical cancer	0.0139	0.015	CbGeAlD
L-Citrulline—DDAH2—lymph node—cervical cancer	0.0137	0.0147	CbGeAlD
L-Citrulline—ASS1—mammalian vulva—cervical cancer	0.0135	0.0145	CbGeAlD
L-Citrulline—DDAH1—lymph node—cervical cancer	0.0132	0.0142	CbGeAlD
L-Citrulline—ASS1—uterus—cervical cancer	0.0128	0.0138	CbGeAlD
L-Citrulline—ASS1—female reproductive system—cervical cancer	0.0115	0.0124	CbGeAlD
L-Citrulline—NOS3—female reproductive system—cervical cancer	0.0115	0.0124	CbGeAlD
L-Citrulline—ASS1—female gonad—cervical cancer	0.0105	0.0113	CbGeAlD
L-Citrulline—ASS1—vagina—cervical cancer	0.0104	0.0112	CbGeAlD
L-Citrulline—NOS3—vagina—cervical cancer	0.0104	0.0112	CbGeAlD
L-Citrulline—ASS1—lymph node—cervical cancer	0.00674	0.00725	CbGeAlD
L-Citrulline—NOS3—lymph node—cervical cancer	0.00672	0.00723	CbGeAlD
L-Citrulline—L-Methionine—MTHFR—cervical cancer	0.00511	1	CrCbGaD
L-Citrulline—NOS3—PAR1-mediated thrombin signaling events—AKAP13—cervical cancer	0.00315	0.0486	CbGpPWpGaD
L-Citrulline—NOS2—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.0031	0.0478	CbGpPWpGaD
L-Citrulline—NOS3—EGF/EGFR Signaling Pathway—PIAS3—cervical cancer	0.0019	0.0293	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—SERPIND1—cervical cancer	0.00165	0.0254	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—GP6—cervical cancer	0.00165	0.0254	CbGpPWpGaD
L-Citrulline—NOS2—ATF-2 transcription factor network—HES1—cervical cancer	0.00156	0.0241	CbGpPWpGaD
L-Citrulline—NOS1—Amyotrophic lateral sclerosis (ALS)—CASP3—cervical cancer	0.00153	0.0237	CbGpPWpGaD
L-Citrulline—NOS2—IL12-mediated signaling events—CD8A—cervical cancer	0.00152	0.0234	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—GP5—cervical cancer	0.00144	0.0222	CbGpPWpGaD
L-Citrulline—NOS2—Circadian rythm related genes—UBE3A—cervical cancer	0.00132	0.0204	CbGpPWpGaD
L-Citrulline—NOS2—IL23-mediated signaling events—CD4—cervical cancer	0.00128	0.0198	CbGpPWpGaD
L-Citrulline—NOS2—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.00125	0.0193	CbGpPWpGaD
L-Citrulline—NOS3—VEGFR2 mediated vascular permeability—MTOR—cervical cancer	0.00125	0.0192	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—SERPIND1—cervical cancer	0.00124	0.0192	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—GP6—cervical cancer	0.00124	0.0192	CbGpPWpGaD
L-Citrulline—NOS1—Alzheimers Disease—CASP8—cervical cancer	0.00113	0.0174	CbGpPWpGaD
L-Citrulline—NOS3—VEGFR2 mediated vascular permeability—CTNNB1—cervical cancer	0.00111	0.0171	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—GP5—cervical cancer	0.00109	0.0168	CbGpPWpGaD
L-Citrulline—NOS2—IL23-mediated signaling events—STAT3—cervical cancer	0.000993	0.0153	CbGpPWpGaD
L-Citrulline—NOS1—Amyotrophic lateral sclerosis (ALS)—TP53—cervical cancer	0.000983	0.0152	CbGpPWpGaD
L-Citrulline—NOS2—AGE/RAGE pathway—CASP8—cervical cancer	0.000983	0.0152	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—SERPIND1—cervical cancer	0.000965	0.0149	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—GP6—cervical cancer	0.000965	0.0149	CbGpPWpGaD
L-Citrulline—NOS1—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—cervical cancer	0.000939	0.0145	CbGpPWpGaD
L-Citrulline—NOS2—IL12-mediated signaling events—MTOR—cervical cancer	0.000873	0.0135	CbGpPWpGaD
L-Citrulline—NOS2—IL12-mediated signaling events—CD4—cervical cancer	0.000871	0.0134	CbGpPWpGaD
L-Citrulline—NOS1—Alzheimers Disease—CASP3—cervical cancer	0.000854	0.0132	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—GP5—cervical cancer	0.000843	0.013	CbGpPWpGaD
L-Citrulline—NOS1—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	0.000819	0.0126	CbGpPWpGaD
L-Citrulline—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.000792	0.0122	CbGpPWpGaD
L-Citrulline—NOS3—AGE/RAGE pathway—CASP8—cervical cancer	0.000763	0.0118	CbGpPWpGaD
L-Citrulline—NOS1—Rac1/Pak1/p38/MMP-2 pathway—EGFR—cervical cancer	0.000744	0.0115	CbGpPWpGaD
L-Citrulline—NOS2—AGE/RAGE pathway—CASP3—cervical cancer	0.000744	0.0115	CbGpPWpGaD
L-Citrulline—NOS2—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—cervical cancer	0.000708	0.0109	CbGpPWpGaD
L-Citrulline—NOS2—IL12-mediated signaling events—STAT3—cervical cancer	0.000675	0.0104	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—CA9—cervical cancer	0.000633	0.00977	CbGpPWpGaD
L-Citrulline—NOS2—AGE/RAGE pathway—STAT3—cervical cancer	0.000625	0.00964	CbGpPWpGaD
L-Citrulline—NOS1—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	0.000625	0.00964	CbGpPWpGaD
L-Citrulline—NOS1—Spinal Cord Injury—CASP3—cervical cancer	0.00062	0.00956	CbGpPWpGaD
L-Citrulline—NOS2—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	0.000618	0.00953	CbGpPWpGaD
L-Citrulline—NOS3—AGE/RAGE pathway—CASP3—cervical cancer	0.000578	0.00891	CbGpPWpGaD
L-Citrulline—NOS2—AGE/RAGE pathway—EGFR—cervical cancer	0.000568	0.00877	CbGpPWpGaD
L-Citrulline—NOS3—Leptin signaling pathway—MTOR—cervical cancer	0.000567	0.00875	CbGpPWpGaD
L-Citrulline—NOS2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—cervical cancer	0.000561	0.00866	CbGpPWpGaD
L-Citrulline—NOS1—Alzheimers Disease—TP53—cervical cancer	0.000548	0.00845	CbGpPWpGaD
L-Citrulline—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—cervical cancer	0.000544	0.00839	CbGpPWpGaD
L-Citrulline—NOS3—Thromboxane A2 receptor signaling—EGFR—cervical cancer	0.000503	0.00776	CbGpPWpGaD
L-Citrulline—NOS3—SHP2 signaling—EGFR—cervical cancer	0.000489	0.00755	CbGpPWpGaD
L-Citrulline—NOS3—AGE/RAGE pathway—STAT3—cervical cancer	0.000485	0.00749	CbGpPWpGaD
L-Citrulline—NOS1—Spinal Cord Injury—EGFR—cervical cancer	0.000473	0.0073	CbGpPWpGaD
L-Citrulline—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	0.000471	0.00727	CbGpPWpGaD
L-Citrulline—NOS2—Spinal Cord Injury—CASP3—cervical cancer	0.000467	0.00721	CbGpPWpGaD
L-Citrulline—NOS3—Corticotropin-releasing hormone—CASP3—cervical cancer	0.000443	0.00683	CbGpPWpGaD
L-Citrulline—NOS3—AGE/RAGE pathway—EGFR—cervical cancer	0.000441	0.00681	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—CA9—cervical cancer	0.000439	0.00677	CbGpPWpGaD
L-Citrulline—NOS3—Leptin signaling pathway—STAT3—cervical cancer	0.000438	0.00676	CbGpPWpGaD
L-Citrulline—NOS3—Corticotropin-releasing hormone—CTNNB1—cervical cancer	0.000427	0.00659	CbGpPWpGaD
L-Citrulline—NOS3—VEGFA-VEGFR2 Pathway—MTOR—cervical cancer	0.000427	0.00658	CbGpPWpGaD
L-Citrulline—NOS1—Disease—WNT2—cervical cancer	0.000412	0.00636	CbGpPWpGaD
L-Citrulline—NOS3—Signaling by VEGF—MTOR—cervical cancer	0.000403	0.00621	CbGpPWpGaD
L-Citrulline—NOS1—Spinal Cord Injury—TP53—cervical cancer	0.000397	0.00613	CbGpPWpGaD
L-Citrulline—NOS3—VEGFA-VEGFR2 Pathway—CTNNB1—cervical cancer	0.000378	0.00584	CbGpPWpGaD
L-Citrulline—NOS3—Signaling by VEGF—CTNNB1—cervical cancer	0.000357	0.00551	CbGpPWpGaD
L-Citrulline—NOS2—Spinal Cord Injury—EGFR—cervical cancer	0.000357	0.00551	CbGpPWpGaD
L-Citrulline—NOS1—Disease—WNT5A—cervical cancer	0.000313	0.00482	CbGpPWpGaD
L-Citrulline—NOS2—Disease—WNT2—cervical cancer	0.000311	0.0048	CbGpPWpGaD
L-Citrulline—NOS3—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	0.000306	0.00472	CbGpPWpGaD
L-Citrulline—NOS2—Spinal Cord Injury—TP53—cervical cancer	0.0003	0.00462	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—MTHFR—cervical cancer	0.000257	0.00397	CbGpPWpGaD
L-Citrulline—NOS3—Disease—WNT2—cervical cancer	0.000242	0.00373	CbGpPWpGaD
L-Citrulline—NOS3—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	0.000237	0.00365	CbGpPWpGaD
L-Citrulline—NOS2—Disease—WNT5A—cervical cancer	0.000236	0.00364	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TAAR6—cervical cancer	0.000217	0.00334	CbGpPWpGaD
L-Citrulline—NOS3—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	0.000215	0.00332	CbGpPWpGaD
L-Citrulline—NOS2—Circadian rythm related genes—TP53—cervical cancer	0.000196	0.00302	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CA9—cervical cancer	0.000191	0.00295	CbGpPWpGaD
L-Citrulline—NOS3—Disease—WNT5A—cervical cancer	0.000183	0.00282	CbGpPWpGaD
L-Citrulline—NOS1—Disease—HES1—cervical cancer	0.00018	0.00278	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—MTHFR—cervical cancer	0.000178	0.00275	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—WNT2—cervical cancer	0.000169	0.00261	CbGpPWpGaD
L-Citrulline—NOS1—Disease—MTHFR—cervical cancer	0.000158	0.00244	CbGpPWpGaD
L-Citrulline—NOS1—Disease—TERT—cervical cancer	0.000158	0.00243	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AKAP13—cervical cancer	0.000149	0.00229	CbGpPWpGaD
L-Citrulline—NOS1—Disease—FGFR3—cervical cancer	0.000145	0.00223	CbGpPWpGaD
L-Citrulline—NOS1—Disease—NOTCH1—cervical cancer	0.000136	0.0021	CbGpPWpGaD
L-Citrulline—NOS2—Disease—HES1—cervical cancer	0.000136	0.00209	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—WNT5A—cervical cancer	0.000128	0.00198	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—TP53—cervical cancer	0.000124	0.00191	CbGpPWpGaD
L-Citrulline—NOS2—Disease—MTHFR—cervical cancer	0.000119	0.00184	CbGpPWpGaD
L-Citrulline—NOS2—Disease—TERT—cervical cancer	0.000119	0.00183	CbGpPWpGaD
L-Citrulline—NOS2—Disease—FGFR3—cervical cancer	0.000109	0.00168	CbGpPWpGaD
L-Citrulline—NOS3—Disease—HES1—cervical cancer	0.000105	0.00163	CbGpPWpGaD
L-Citrulline—NOS2—Disease—NOTCH1—cervical cancer	0.000102	0.00158	CbGpPWpGaD
L-Citrulline—NOS1—Disease—MTOR—cervical cancer	0.000102	0.00157	CbGpPWpGaD
L-Citrulline—NOS1—Disease—CD4—cervical cancer	0.000102	0.00157	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—TP53—cervical cancer	9.35e-05	0.00144	CbGpPWpGaD
L-Citrulline—NOS3—Disease—MTHFR—cervical cancer	9.26e-05	0.00143	CbGpPWpGaD
L-Citrulline—NOS3—Disease—TERT—cervical cancer	9.23e-05	0.00142	CbGpPWpGaD
L-Citrulline—NOS1—Disease—CTNNB1—cervical cancer	9.02e-05	0.00139	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NOTCH2—cervical cancer	9e-05	0.00139	CbGpPWpGaD
L-Citrulline—NOS3—Disease—FGFR3—cervical cancer	8.47e-05	0.00131	CbGpPWpGaD
L-Citrulline—NOS3—Disease—NOTCH1—cervical cancer	7.95e-05	0.00123	CbGpPWpGaD
L-Citrulline—NOS1—Disease—STAT3—cervical cancer	7.86e-05	0.00121	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—MTHFR—cervical cancer	7.75e-05	0.0012	CbGpPWpGaD
L-Citrulline—NOS2—Disease—MTOR—cervical cancer	7.68e-05	0.00118	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CD4—cervical cancer	7.66e-05	0.00118	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HES1—cervical cancer	7.38e-05	0.00114	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—TP53—cervical cancer	7.26e-05	0.00112	CbGpPWpGaD
L-Citrulline—NOS1—Disease—EGFR—cervical cancer	7.15e-05	0.0011	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CTNNB1—cervical cancer	6.8e-05	0.00105	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TERT—cervical cancer	6.46e-05	0.000998	CbGpPWpGaD
L-Citrulline—NOS3—Disease—MTOR—cervical cancer	5.96e-05	0.00092	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CD4—cervical cancer	5.95e-05	0.000918	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FGFR3—cervical cancer	5.93e-05	0.000915	CbGpPWpGaD
L-Citrulline—NOS2—Disease—STAT3—cervical cancer	5.93e-05	0.000915	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NOTCH1—cervical cancer	5.57e-05	0.000859	CbGpPWpGaD
L-Citrulline—NOS2—Disease—EGFR—cervical cancer	5.39e-05	0.000832	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CTNNB1—cervical cancer	5.28e-05	0.000815	CbGpPWpGaD
L-Citrulline—NOS3—Disease—STAT3—cervical cancer	4.61e-05	0.000711	CbGpPWpGaD
L-Citrulline—NOS3—Disease—EGFR—cervical cancer	4.19e-05	0.000646	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MTOR—cervical cancer	4.17e-05	0.000644	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CASP3—cervical cancer	3.84e-05	0.000592	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CTNNB1—cervical cancer	3.7e-05	0.000571	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—STAT3—cervical cancer	3.23e-05	0.000498	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—EGFR—cervical cancer	2.93e-05	0.000452	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TP53—cervical cancer	2.46e-05	0.00038	CbGpPWpGaD
